Abstracts

575 – Continuous Increase in HIV-1 Resistance to Neutralization by bNAbs Over the Past 30 Years

Background The efficacy of broadly neutralizing antibodies (bNAbs) is affected by the genetic diversity of HIV-1 and the ongoing escape from autologous neutralizing Abs at the population level. We investigated the current state of neutralization sensitivity of recent transmitted/founder (T/F) variants, with a focus on subtype B and CRF02_AG, the predominant clades in North America,…

578 – In Vivo Escape Pathways to VRC07-523LS and VRC01LS and Their Effects on CD4bs bNAb Susceptibility

Background Substantial inter- and intra-individual HIV diversity remains a major challenge in developing successful immune-based therapies. Despite the ability of broadly neutralizing antibodies (bNAbs) to neutralize genetically diverse strains, viral escape mutations can still emerge in vivo. To overcome this, it is essential to gain a deeper understanding of the in vivo evolution of HIV…

595 – Impact of HIV PrEP on Female Sex Workers With Hepatitis B: A Modeling Analysis in Côte d’Ivoire

Background More than 10% of the 2.5 million sex workers in sub-Saharan Africa live with chronic hepatitis B virus (HBV). HIV pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (TDF/FTC) has not been studied in this population, in part due to concerns of hepatitis flares following TDF/FTC cessation.  Methods Using the CEPAC simulation model of HIV and HBV…

605 – Vitamin D Status and Hepatic Steatosis in People With HIV: Evidence From Paired Measurements

Background Vitamin D insufficiency and metabolic dysfunction-associated steatotic liver disease (MASLD) are highly prevalent in people with HIV (PWH). Evidence suggests vitamin D may modulate hepatic fat accumulation, but data in HIV are limited. We assessed the relationship between serum 25-hydroxyvitamin D [25(OH)D] and hepatic steatosis severity in a prospective cohort with paired transient elastography…

875 – Parental Communication and HIV Care Outcomes Among African Adolescents and Young Adults

Background Adolescents and young adults living with HIV (ALWH) experience suboptimal outcomes along the HIV care cascade. Family support, including communication between youth and parents or guardians, may influence HIV testing and treatment uptake, and viral suppression. Using population-representative HIV surveys, we described the relationship of parental communication and HIV care cascade outcomes among ALWH. …

974 – HIV Self-Testing by Motorcycle-Taxi Drivers: A Novel Approach for Case Detection in Kampala, Uganda

Background Only 80.9% of adults living with HIV in Uganda are aware of their HIV status, indicating a significant testing gap and barrier to treatment as prevention. Until people become aware of their HIV status, get treated, and achieve viral load suppression, HIV transmission will continue. Mengo Hospital, a private not-for-profit hospital in Kampala, Uganda,…

589 – MDL-001, a Novel Oral Thumb-1 Polymerase Inhibitor, Shows Efficacy in HCV/HBV In Vitro and In Vivo

Background MDL-001 is a first-in-category oral direct-acting non-nucleoside inhibitor that binds a previously underexploited allosteric pocket in the Thumb-1 domain of viral polymerase. We assessed inhibition of hepatitis C virus (HCV) and hepatitis B virus (HBV) in mono- and co-infection in vitro, established HCV and HBV proof-of-concept (POC) in vivo, and summarized nonclinical pharmacokinetic (PK)…

844 – Susceptibility Patterns for VRC07-523LS, PGDM1400LS, and PGT121.414.LS Among Children in Botswana

Background Broadly neutralizing antibodies (bNAbs) are being investigated as part of HIV remission strategies in children. We examined baseline bNAb neutralization profiles in participants from the Tatelo Plus (IMPAACT 2042) study, which is evaluating VRC07-523LS, PGDM1400LS, and PGT121.414.LS among early-treated children in Botswana. Methods Twelve virally suppressed children who initiated antiretroviral treatment <7 days of…